Preventing brain atrophy should be the gold standard of effective theraphy in MS (after the first year of treatment): No

Multiple Sclerosis Journal

Volumn 19, Issue 8, 2013, Pages 1005-1006

  Filippi, M ^a   Rocca, M A ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN ATROPHY; BRAIN SIZE; DEMYELINATION; DIFFUSION TENSOR IMAGING; DISEASE COURSE; HUMAN; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PROTON NUCLEAR MAGNETIC RESONANCE; TREATMENT RESPONSE;

EID: 84879755259     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513482387     Document Type: Article

References (11)

1. Inglese M, Mancardi GL, Pagani E, et al. Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation. J Neurol Neurosurg Psychiatry. 2004 ; 75: 643-4 (Pubitemid 38406670)
2. Filippi M, Rovaris M, Inglese M, et al. Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet. 2004 ; 364: 1489-96 (Pubitemid 39410414)
3. Barkhof F, Calabresi PA, Miller DH, Reingold SC. Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nat Rev Neurol. 2009 ; 5: 256-66
4. Zivadinov R, Reder AT, Filippi M, et al. Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis. Neurology. 2008 ; 71: 136-44
5. Filippi M, Rocca MA. MR Imaging of Multiple Sclerosis. Radiology. 2011 ; 259: 659-81
6. Rocca MA, Agosta F, Sormani MP, et al. A three-year, multi-parametric MRI study in patients at presentation with CIS. J Neurol. 2008 ; 255: 683-91
7. Pagani E, Hirsch JG, Pouwels PJ, et al. Intercenter differences in diffusion tensor MRI acquisition. J Magn Reson Imaging. 2010 ; 31: 1458-68
8. De Stefano N, Filippi M, Miller D, et al. Guidelines for using proton MR spectroscopy in multicenter clinical MS studies. Neurology. 2007 ; 69: 1942-52 (Pubitemid 350100353)
9. Fisher E, Lee JC, Nakamura K, Rudick RA. Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol. 2008 ; 64: 255-65
10. Geurts JJ, Calabrese M, Fisher E, Rudick RA. Measurement and clinical effect of grey matter pathology in multiple sclerosis. Lancet Neurol. 2012 ; 11: 1082-92
11. Rocca MA, Horsfield MA, Sala S, et al. A multicenter assessment of cervical cord atrophy among MS clinical phenotypes. Neurology. 2011 ; 76: 2096-102